Publicaciones (47) Publicaciones de Laura Fernández García

2024

  1. Factores asociados y respuesta clínica en el tratamiento del hombro doloroso mediante bloqueo del nervio supraescapular

    Revista electrónica AnestesiaR, Vol. 16, Núm. 3

  2. Improving phage therapy by evasion of phage resistance mechanisms

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 1

  3. Phages produce persisters

    Microbial Biotechnology, Vol. 17, Núm. 8

  4. Regulation of anti-phage defense mechanisms by using cinnamaldehyde as a quorum sensing inhibitor

    Frontiers in Microbiology, Vol. 15

  5. Single-cell analysis reveals that cryptic prophage protease LfgB protects Escherichia coli during oxidative stress by cleaving antitoxin MqsA

    Microbiology spectrum, Vol. 12, Núm. 2, pp. e0347123

  6. Toxin/antitoxin systems induce persistence and work in concert with restriction/modification systems to inhibit phage

    Microbiology spectrum, Vol. 12, Núm. 1, pp. e0338823

2023

  1. CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases

    Microbiology spectrum, Vol. 11, Núm. 4, pp. e0132923

  2. Molecular studies of phages-Klebsiella pneumoniae in mucoid environment: innovative use of mucolytic agents prior to the administration of lytic phages

    Frontiers in Microbiology, Vol. 14

  3. Phage-Defense Systems Are Unlikely to Cause Cell Suicide

    Viruses

  4. Proteomic Study of the Interactions between Phages and the Bacterial Host Klebsiella pneumoniae

    Microbiology Spectrum, Vol. 11, Núm. 2

  5. Ribosome inactivation by Escherichia coli GTPase RsgA inhibits T4 phage

    Frontiers in Microbiology, Vol. 14

  6. Study of 32 new phage tail-like bacteriocins (pyocins) from a clinical collection of Pseudomonas aeruginosa and of their potential use as typing markers and antimicrobial agents

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-β-naphthylamide (PaβN): co-resistance to antimicrobials

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 5, pp. 1272-1281

  2. CRISPR-Cas Controls Cryptic Prophages

    International Journal of Molecular Sciences, Vol. 23, Núm. 24

  3. Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the Host

    Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 3

  4. Genomic Analysis of Molecular Bacterial Mechanisms of Resistance to Phage Infection

    Frontiers in Microbiology, Vol. 12

  5. Phenotypic and genomic comparison of klebsiella pneumoniae lytic phages: Vb_kpnm-vac66 and vb_kpnm-vac13

    Viruses, Vol. 14, Núm. 1

  6. Reverse Transcription-Loop-Mediated Isothermal Amplification-CRISPR-Cas13a Technology as a Promising Diagnostic Tool for SARS-CoV-2

    Microbiology spectrum, Vol. 10, Núm. 5, pp. e0239822

  7. The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection

    Scientific Reports, Vol. 12, Núm. 1

  8. What are the options for treating infections by persister-forming pathogens?

    Environmental Microbiology, Vol. 24, Núm. 10, pp. 4500-4504